ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2,1,Bradycardia neonatal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
2,2,Device failure,Device issues NEC,Device issues,Prod,N
3,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
3,3,Right ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
3,4,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
4,1,Device issue,Device issues NEC,Device issues,Prod,N
4,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,Y
4,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
6,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
7,1,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
8,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
